TIMP2 and ovarian carcinoma: However, the concurrent enhanced expression of TIMP-2, -3 and MMP-9, -11, -14 observed in ovarian carcinomas is conflicting with the potential inhibitory actions of the TIMPs on MMPs and requires further investigation (72).